Fangfang Song

2.8k citations
91 papers · 2.1k indexed · h-index 24
Topics
Breast Cancer Treatment Studies (9 papers)Heme Oxygenase-1 and Carbon Monoxide (8 papers)Cancer Risks and Factors (8 papers)
Journals
SHILAP Revista de lepidopterologíaPLoS ONEAmerican Journal of Clinical Nutrition

In The Last Decade

Fangfang Song

83 papers receiving 2.0k citations

Peers

Fangfang Song
Comparison fields: 5 of 140
  • Molecular Biology 908
  • Cancer Research 358
  • Pathology and Forensic Medicine 285
  • Epidemiology 189
  • Oncology 184
Replace Monisha Banerjee with:
Monisha Banerjee India
Adel R. A. Abd‐Allah Egypt
Chao Tong China
Runping Liu China
Dong Kwon Yang South Korea
Zhiqing He China
Liyong Chen China
Huaping Liang China
Indu Singh Australia
Hongxia Xu China
Fangfang Song relative to Monisha Banerjee India Monisha Banerjee's profile →
Citations per field
00.5×2.6×
Monisha Banerjee · 1×
Citations per year

Countries citing papers authored by Fangfang Song

Since Specialization
Citations

This map shows the geographic impact of Fangfang Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangfang Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangfang Song more than expected).

Fields of papers citing papers by Fangfang Song

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangfang Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangfang Song. The network helps show where Fangfang Song may publish in the future.

Co-authorship network of co-authors of Fangfang Song

This figure shows the co-authorship network connecting the top 25 collaborators of Fangfang Song. A scholar is included among the top collaborators of Fangfang Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangfang Song. Fangfang Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 6
2 1
3 3
4 3
5 5
6 0
7 2
8 0
9 0
10 9
11 10
12 1
13 9
14 4
15 5
16 1
17 7
18 12
19 16
20 20

About Fangfang Song

Fangfang Song is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology, having authored 91 papers that have together received 2.1k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (9 papers), Heme Oxygenase-1 and Carbon Monoxide (8 papers) and Cancer Risks and Factors (8 papers). The work is most often cited by research in Cancer Research (358 citations), Biochemistry (100 citations) and Ceramics and Composites (95 citations). Fangfang Song has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Liegang Liu, Ping Yao, Andreas K. Nüssler, Liping Hao, Kexin Chen, Natascha C. Nüssler, Anja Schirmeier, Xiufa Sun, Qingyi Wei and Wei Zhang. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Clinical Nutrition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026